Skip to content

Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit

Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03920670
Enrollment
120
Registered
2019-04-19
Start date
2019-02-28
Completion date
2020-11-30
Last updated
2021-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Residual Neuromuscular Blockade

Keywords

Neuromuscular Blockade, ToFscan, Tetragraph, AMG, EMG

Brief summary

The aim of this investigation is to compare the performance of two quantitative monitors utilized on post-anesthesia recovering patients. The ToFscan (Draeger Medical Inc., Telford, PA) represents one of the few standalone acceleromyography (AMG)-based quantitative monitors available for routine clinical use in the United States. The TetraGraph (Senzime AB, Uppsala, Sweden) is a standalone electromyography (EMG)-based quantitative monitor that recently received Conformité Européene (CE) approval. While both of these quantitative monitors can be utilized to guide intraoperative NMBA re-dosing and confirm recovery, they provide their objective data via drastically different techniques.

Interventions

DEVICETetraGraph (TG)

TetraGraph device is a neuromuscular transmission monitor capable of estimating the depth of neuromuscular block in anesthetized patients who received neuromuscular blocking agents. TetraGraph uses EMG to measure the muscle action potentials that are generated in response to percutaneous electrical neurostimulation. Following simultaneous ulnar nerve stimulation on each arm, the response of the adductor pollicis will be measured.

DEVICEToFscan (TS)

ToFscan is a nerve stimulator module used for the measurement of neuromuscular transmission via accelerometry. ToFscan was developed by Drager Technologies, Canada, and it uses a three-dimensional piezoelectric sensor that attaches to the thumb via a hand adapter to measure acceleration in multiple planes (Murphy et al, 2018). Following simultaneous ulnar nerve stimulation on each arm, the response of the adductor pollicis will be measured.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> or = 18 years old * Patients willing to participate and provide an informed consent * Patients undergoing an elective surgical procedure that requires use of non-depolarizing NMBA agents administered intraoperatively.

Exclusion criteria

* Patients with unilateral disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury. * Patients with systemic neuromuscular diseases such as myasthenia gravis * Patients with significant organ dysfunction that can significantly affect pharmacokinetics of neuromuscular blocking and reversal agents, i.e., severe renal impairment or end-stage liver disease.

Design outcomes

Primary

MeasureTime frameDescription
Mean Train-of-Four Ratios (TOFR's)baseline, after 5 minutes, after + 10 minutesTrain-of-four ratios is the ratio of the fourth muscle response to the first one.

Countries

Hungary, United States

Participant flow

Participants by arm

ArmCount
Tetragraph (TG) Dominant Hand ToFscan (TS) Non-dominant Hand
TetraGraph was placed on dominant hand, ToFscan was placed on non-dominant hand TetraGraph device is a neuromuscular transmission monitor capable of estimating the depth of neuromuscular block in anesthetized patients who received neuromuscular blocking agents. TetraGraph uses EMG to measure the muscle action potentials that are generated in response to percutaneous electrical neurostimulation. Following simultaneous ulnar nerve stimulation on each arm, the response of the adductor pollicis was measured. ToFscan is a nerve stimulator module used for the measurement of neuromuscular transmission via accelerometry. ToFscan was developed by Drager Technologies, Canada, and it uses a three dimensional piezoelectric sensor that attaches to the thumb via a hand adapter to measure acceleration in multiple planes (Murphy et al, 2018). Following simultaneous ulnar nerve stimulation on each arm, the response of the adductor pollicis was measured.
60
ToFscan (TS) Dominant Hand TetraGraph (TG) Non-dominant Hand
ToFscan was placed on dominant hand, TetraGraph (TG) was placed on non-dominant hand TetraGraph device is a neuromuscular transmission monitor capable of estimating the depth of neuromuscular block in anesthetized patients who received neuromuscular blocking agents. TetraGraph uses EMG to measure the muscle action potentials that are generated in response to percutaneous electrical neurostimulation. Following simultaneous ulnar nerve stimulation on each arm, the response of the adductor pollicis was measured. ToFscan is a nerve stimulator module used for the measurement of neuromuscular transmission via accelerometry. ToFscan was developed by Drager Technologies, Canada, and it uses a three dimensional piezoelectric sensor that attaches to the thumb via a hand adapter to measure acceleration in multiple planes (Murphy et al, 2018). Following simultaneous ulnar nerve stimulation on each arm, the response of the adductor pollicis was measured.
60
Total120

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event10
Overall StudyProtocol Violation22

Baseline characteristics

CharacteristicToFscan (TS) Dominant Hand TetraGraph (TG) Non-dominant HandTotalTetragraph (TG) Dominant Hand ToFscan (TS) Non-dominant Hand
Age, Continuous55.6 years
STANDARD_DEVIATION 15.1
55.6 years
STANDARD_DEVIATION 15.2
55.5 years
STANDARD_DEVIATION 15.2
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
60 participants120 participants60 participants
Sex: Female, Male
Female
38 Participants74 Participants36 Participants
Sex: Female, Male
Male
22 Participants46 Participants24 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1150 / 115
other
Total, other adverse events
0 / 1150 / 115
serious
Total, serious adverse events
0 / 1150 / 115

Outcome results

Primary

Mean Train-of-Four Ratios (TOFR's)

Train-of-four ratios is the ratio of the fourth muscle response to the first one.

Time frame: baseline, after 5 minutes, after + 10 minutes

Population: Dominant arm Train-of-Four Ratios collected for analysis

ArmMeasureGroupValue (MEAN)Dispersion
Tetragraph (TG) Dominant Hand ToFscan (TS) Non-dominant HandMean Train-of-Four Ratios (TOFR's)after + 10 minutes0.99 RatioStandard Deviation 0.014
Tetragraph (TG) Dominant Hand ToFscan (TS) Non-dominant HandMean Train-of-Four Ratios (TOFR's)baseline0.97 RatioStandard Deviation 0.18
Tetragraph (TG) Dominant Hand ToFscan (TS) Non-dominant HandMean Train-of-Four Ratios (TOFR's)after 5 minutes0.96 RatioStandard Deviation 0.2
ToFscan (TS) Dominant Hand TetraGraph (TG) Non-dominant HandMean Train-of-Four Ratios (TOFR's)baseline0.94 RatioStandard Deviation 0.13
ToFscan (TS) Dominant Hand TetraGraph (TG) Non-dominant HandMean Train-of-Four Ratios (TOFR's)after 5 minutes0.95 RatioStandard Deviation 0.12
ToFscan (TS) Dominant Hand TetraGraph (TG) Non-dominant HandMean Train-of-Four Ratios (TOFR's)after + 10 minutes0.94 RatioStandard Deviation 0.12

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026